Authors:
HE K
IYER KR
HAYES RN
SINZ MW
WOOLF TF
HOLLENBERG PF
Citation: K. He et al., INACTIVATION OF CYTOCHROME-P450 3A4 BY BERGAMOTTIN, A COMPONENT OF GRAPEFRUIT JUICE, Chemical research in toxicology, 11(4), 1998, pp. 252-259
Authors:
FONTANA RJ
DEVRIES TM
WOOLF TF
KNAPP MJ
BROWN AS
KAMINSKY LS
TANG BK
FOSTER NL
BROWN RR
WATKINS PB
Citation: Rj. Fontana et al., CAFFEINE BASED MEASURES OF CYP1A2 ACTIVITY CORRELATE WITH ORAL CLEARANCE OF TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE, British journal of clinical pharmacology, 46(3), 1998, pp. 221-228
Citation: Wf. Pool et al., METABOLIC DISPOSITION OF THE COGNITION ACTIVATOR TACRINE IN RATS, DOGS, AND HUMANS - SPECIES COMPARISONS, Drug metabolism and disposition, 25(5), 1997, pp. 590-597
Authors:
SINZ MW
BLACK AE
BJORGE SM
HOLMES A
TRIVEDI BK
WOOLF TF
Citation: Mw. Sinz et al., IN-VITRO AND IN-VIVO DISPOSITION OF ,2-DIMETHYL-N-(2,4,6-TRIMETHOXYPHENYL)DIDECANAMIDE (CL-976) - IDENTIFICATION OF A NOVEL 5-CARBON CLEAVAGE METABOLITE IN RATS, Drug metabolism and disposition, 25(1), 1997, pp. 123-130
Citation: Mw. Sinz et Tf. Woolf, CHARACTERIZATION OF THE INDUCTION OF RAT MICROSOMAL CYTOCHROME-P450 BY TACRINE, Biochemical pharmacology, 54(3), 1997, pp. 425-427
Citation: Rj. Fontana et al., THE CAFFEINE BREATH TEST DOES NOT IDENTIFY PATIENTS SUSCEPTIBLE TO TACRINE HEPATOTOXICITY, Hepatology, 23(6), 1996, pp. 1429-1435
Authors:
MCNALLY WP
POOL WF
SINZ MW
DEHART P
ORTWINE DF
HUANG CC
CHANG T
WOOLF TF
Citation: Wp. Mcnally et al., DISTRIBUTION OF TACRINE AND METABOLITES IN RAT-BRAIN AND PLASMA AFTERSINGLE-AND MULTIPLE-DOSE REGIMENS - EVIDENCE FOR ACCUMULATION OF TACRINE IN BRAIN-TISSUE, Drug metabolism and disposition, 24(6), 1996, pp. 628-633
Citation: S. Bezek et al., THE EFFECT OF CYTOCHROMES P4501A INDUCTION AND INHIBITION ON THE DISPOSITION OF THE COGNITION ACTIVATOR TACRINE IN RAT HEPATIC PREPARATIONS, Xenobiotica, 26(9), 1996, pp. 935-946
Citation: Wf. Pool et al., IDENTIFICATION OF A 3-HYDROXYLATED TACRINE METABOLITE IN RAT AND MAN - METABOLIC PROFILING IMPLICATIONS AND PHARMACOLOGY, Journal of medicinal chemistry, 39(15), 1996, pp. 3014-3018
Authors:
SPALDIN V
MADDEN S
POOL WF
WOOLF TF
PARK BK
Citation: V. Spaldin et al., THE EFFECT OF ENZYME-INHIBITION ON THE METABOLISM AND ACTIVATION OF TACRINE BY HUMAN LIVER-MICROSOMES, British journal of clinical pharmacology, 38(1), 1994, pp. 15-22
Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF CAFFEINE TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Hepatology, 19(4), 1994, pp. 90000063-90000063
Citation: M. Kukan et al., METABOLIC DISPOSITION OF TACRINE IN PRIMARY SUSPENSIONS OF RAT HEPATOCYTE AND IN SINGLE-PASS PERFUSED LIVER - IN-VITRO IN-VIVO COMPARISONS, Xenobiotica, 24(11), 1994, pp. 1107-1117
Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF METABOLIC PROBES TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Gastroenterology, 106(4), 1994, pp. 10000893-10000893
Authors:
WOOLF TF
BLACK A
SHUM YY
MCNALLY W
LEE H
CHANG T
Citation: Tf. Woolf et al., BIODISPOSITION STUDIES WITH THE ACYL-COENZYME-A - CHOLESTEROL ACYLTRANSFERASE INHIBITOR 2-DIMETHYL-N-(2,4,6-TRIMETHOXYPHENYL)DODECANAMIDE, CI-976, Drug metabolism and disposition, 21(6), 1993, pp. 1112-1118
Authors:
WOOLF TF
POOL WF
BJORGE SM
CHANG T
GOEL OP
PURCHASE CF
SCHROEDER MC
KUNZE KL
TRAGER WF
Citation: Tf. Woolf et al., BIOACTIVATION AND IRREVERSIBLE BINDING OF THE COGNITION ACTIVATOR TACRINE USING HUMAN AND RAT-LIVER MICROSOMAL PREPARATIONS - SPECIES-DIFFERENCE, Drug metabolism and disposition, 21(5), 1993, pp. 874-882
Citation: M. Kukan et al., CHARACTERIZATION OF NONLINEAR ELIMINATION OF THE XANTHINE-RELATED DRUG ETHIMIZOL IN 3-METHYLCHOLANTHRENE-INDUCED RAT-LIVER BY THE PARALLEL-TUBE MODEL, Drug metabolism and disposition, 21(3), 1993, pp. 547-550
Citation: S. Madden et al., AN INVESTIGATION INTO THE FORMATION OF STABLE, PROTEIN-REACTIVE AND CYTOTOXIC METABOLITES FROM TACRINE IN-VITRO - STUDIES WITH HUMAN AND RAT-LIVER MICROSOMES, Biochemical pharmacology, 46(1), 1993, pp. 13-20